- Forums
- ASX - By Stock
- IDT
- Ann: Strong Q4 Pushes Full-Year Revenue Ahead of Guidance
Ann: Strong Q4 Pushes Full-Year Revenue Ahead of Guidance, page-22
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IDT (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $49.43M |
Open | High | Low | Value | Volume |
11.5¢ | 11.5¢ | 11.0¢ | $64.30K | 576.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 457133 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 8130 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 457133 | 0.105 |
4 | 163000 | 0.100 |
1 | 30000 | 0.099 |
1 | 18199 | 0.055 |
1 | 60000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 8130 | 2 |
0.115 | 100000 | 1 |
0.120 | 151064 | 4 |
0.125 | 250000 | 2 |
0.130 | 202341 | 2 |
Last trade - 12.45pm 13/11/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online